Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) announced that its board has authorized a share buyback program on Wednesday, October 1st, RTT News reports. Get Catalyst Pharmaceuticals alerts:Catalyst Pharmaceuticals Price PerformanceCPRX opened at $20.91 on Thursday. Catalyst Pharmaceuticals has a 1 year low of $19.05 and a 1 year high of $26.58. Catalyst Pharmaceuticals Company ProfileGet Free Report)Catalyst Pharmaceuticals, Inc, a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. Read MoreReceive News & Ratings for Catalyst Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalyst Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.